Skip to content

Evaluating the Value of Audio-guided Meditation During Breast Biopsy Procedures

Evaluating the Value of Audio-guided Meditation During Breast Biopsy Procedures

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05343975
Acronym
MAG-BM
Enrollment
225
Registered
2022-04-25
Start date
2022-03-02
Completion date
2023-11-02
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Disease

Brief summary

A prospective, non-randomized, single-center cohort study to evaluate the value of audio-guided meditation during breast biopsy procedures. The main criterion of judgment is based on the evaluation of tolerance, which includes anxiety and pain felt. This is assessed with questionnaires (STAI-ETAT and EN) before and after the procedure. Secondary endpoints include tolerance of additional physical pain, reduction in the number of per-procedure complications, overall satisfaction of the practitioner with the biopsy procedure, and comparison of the tolerance of the procedure in patients who practice meditation at home before the procedure

Detailed description

audio-guided meditation during breast biopsy procedures questionnaires (STAI-ETAT and EN) before and after the procedure.

Interventions

PROCEDUREbiopsy with audio-guided Meditation

biopsy with audio-guided Meditation

Sponsors

Institut Cancerologie de l'Ouest
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Breast pathology requiring the performance of one (or more) breast and/or axillary micro or macrobiopsy, * Informed patient, with collection of the non opposition

Exclusion criteria

* Excluded forms of the disease: biopsy concerning organs other than the breast and/or axilla * Persons deprived of their liberty, under court protection, under curatorship or under the authority of a guardian, * Impossibility to submit to the medical follow-up of the trial for geographical, social or psychic reasons (invalidating psychiatric disorder diagnosed of psychotic type).

Design outcomes

Primary

MeasureTime frameDescription
To describe the level of pain according to whether or not patients listen to audio-guided mediation during the breast biopsy procedureimmediately after procedure11-point numerical scale (from 0 = no pain to 10 = maximal pain)
To describe anxiety according to whether or not patients listen to audio-guided mediation during the breast biopsy procedureimmediately after procedureState Trait Anxiety Inventory Etat - Trait (40 questions - each item has a score from 1 to 4 (4 being the highest level of anxiety))

Secondary

MeasureTime frameDescription
per-biopsy complicationsimmediately after procedure (same day of the biopsy)complications
satisfaction of the radiologist with regard to the procedureimmediately after procedurequestions about 1. overall quality of the doctor-patient relationship and 2. Patient compliance with the procedure with scales in 4 point
efficacy of the procedureimmediately after procedurenumber of samples taken in the target

Countries

France

Contacts

PRINCIPAL_INVESTIGATORPierre BERGE, MD

INSTITUT DE CANCEROLOGIE DE L'OUEST

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026